Related Experiment Video
Updated: Aug 10, 2026
Calcification of Vascular Smooth Muscle Cells and Imaging of Aortic Calcification and Inflammation
Published on: May 31, 2016
Exploring the connection between chronic renal fibrosis and bone morphogenic protein-7
1Harvard Medical School, Program in Matrix Biology, Department of Medicine, Dana 514, Beth Israel Deaconess Medical Center, 330 Brookline Avenue, Boston, MA 02215, USA. rkalluri@caregroup.harvard.edu
Abstract:
Tubulointerstitial fibrosis is a hallmark feature of chronic renal injury. Specific therapies to control the progression of renal fibrosis towards end-stage renal failure are still limited. Transforming growth factor-beta1 (TGF-beta1) has been identified as a major mediator of renal fibrosis. Recent reports have suggested that Bone Morphogenic Protein-7 (BMP-7), another member of the TGF-beta superfamily, accelerates repair of acute renal injury and ameliorates progression of chronic renal fibrosis in a variety of animal models. Interestingly, BMP-7, an endogenous molecule which is present in the normal kidney, vastly decreases its expression during renal injury. Although, the mechanism of BMP-7 action in the kidney is not yet fully understood, the idea of an endogenous molecule with reno-protective function is intriguing.
Insights
Bone Morphogenic Protein-7 (BMP-7) may protect kidneys from chronic injury. This endogenous molecule, decreased during renal damage, shows promise in treating tubulointerstitial fibrosis and preventing kidney failure.
Area of Science:
- Nephrology
- Regenerative Medicine
- Molecular Biology
Background:
- Tubulointerstitial fibrosis is a key indicator of chronic kidney disease.
- Current therapies for renal fibrosis progression are limited.
- Transforming growth factor-beta1 (TGF-beta1) is a primary driver of renal fibrosis.
Purpose of the Study:
- To explore the potential of Bone Morphogenic Protein-7 (BMP-7) in mitigating chronic renal fibrosis.
- To investigate BMP-7's reno-protective role in kidney injury.
Main Methods:
- Review of existing literature on BMP-7 and renal fibrosis.
- Analysis of BMP-7's expression patterns in normal versus injured kidneys.
- Examination of BMP-7's therapeutic potential in animal models of renal injury.
Main Results:
- BMP-7, a member of the TGF-beta superfamily, has demonstrated accelerated repair in acute renal injury.
- BMP-7 ameliorates chronic renal fibrosis progression in various animal models.
- Endogenous BMP-7 levels significantly decrease during renal injury, despite its presence in healthy kidneys.
Conclusions:
- BMP-7 represents a potential endogenous therapeutic agent for chronic kidney disease.
- Further research into BMP-7's mechanism of action is warranted to understand its reno-protective functions.
- Targeting BMP-7 could offer novel strategies for controlling renal fibrosis and preventing end-stage renal failure.
